Wynestron en es it fr

Wynestron Brand names, Wynestron Analogs

Wynestron Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Wynestron Chemical_Formula

C18H22O2

Wynestron RX_link

No information avaliable

Wynestron fda sheet

Wynestron msds (material safety sheet)

Wynestron MSDS

Wynestron Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Wynestron Molecular Weight

270.366 g/mol

Wynestron Melting Point

254.5-256 oC

Wynestron H2O Solubility

3 g/100mL

Wynestron State

Solid

Wynestron LogP

4.067

Wynestron Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Wynestron Indication

For management of Menopausal and postmenopausal disorders

Wynestron Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Wynestron Absorption

43%

Wynestron side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Wynestron Patient Information

Wynestron Organisms Affected

Humans and other mammals